Home   >  
Protease/Metabolic Enzyme
  • Protease/Metabolic Enzyme
  • Neuro Signaling Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
LY2183240 Chemical Structure
BCP22610 LY2183240 874902-19-9
LY2183240 is a novel and highly potent blocker of anandamide uptake (IC50 = 270 pM).
ARN272 Chemical Structure
BCP17386 ARN272 488793-85-7
ARN 272 is a FAAH-like anandamide transporter (FLAT) inhibitor (IC50 = 1.8 μM); cytosolic variant of FAAH-1 that binds anandamide.
JZL195 Chemical Structure
BCP23894 JZL195 1210004-12-8
JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor with IC50 of 13 nM and 19 nM for mouse brain FAAH and MAGL respectively.
BIA10-2474 Chemical Structure
BCP29970 BIA10-2474 1233855-46-3
BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
JNJ1661010 Chemical Structure
BCP06935 JNJ1661010 681136-29-8
JNJ-1661010 is a potent and selective FAAH inhibitor with IC50 of 10 nM (rat) and 12 nM (human), exhibits >100-fold selectivity for FAAH-1 when compared to FAAH-2.
ArachidonylethanolaMide Chemical Structure
BCP16072 ArachidonylethanolaMide 94421-68-8
It is degraded primarily by the fatty acid amide hydrolase (FAAH) enzyme, which converts anandamid.
JNJ42165279 Chemical Structure
BCP16594 JNJ42165279 1346528-50-4
JNJ-42165279 is a FAAH inhibitor with IC50 of 70 ± 8 nM and 313 ± 28 nM for hFAAH and rFAAH, respectively.
URB597 Chemical Structure
BCP27727 URB597 546141-08-6
URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets.
PF3845 Chemical Structure
BCP02317 PF3845 1196109-52-0
PF-3845 (PF 3845) is a selective fatty acid amide hydrolase (FAAH) inhibitor (Ki = 0.23 μM).
PF-04457845 Chemical Structure
BCP05805 PF-04457845 1020315-31-4
PF-04457845 is a potent and exquisitely selective inhibitor of FAAH, with an IC50 of 7.2 nM, and both analgesic and antiinflammatory effects in animal studies comparable to naproxen.